William Bradley Hayes's most recent trade in Indaptus Therapeutics Inc was a trade of 12,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Indaptus Therapeutics Inc | William Bradley Hayes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Builders FirstSource | William Bradley Hayes | Director | Grant, award, or other acquisition of securities at price $ 107.68 per share. | 01 Jun 2025 | 359 | 15,577 (0%) | 0% | 107.7 | 38,657 | Common Stock, par value $0.01 per share |
| Builders FirstSource | William Bradley Hayes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 1,707 | 15,218 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Indaptus Therapeutics Inc | William Bradley Hayes | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Apr 2025 | 500 | 0 | - | - | Stock Option (right to buy) | |
| Indaptus Therapeutics Inc | William Bradley Hayes | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Apr 2025 | 250 | 0 | - | - | Stock Option (right to buy) | |
| Indaptus Therapeutics Inc | William Bradley Hayes | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Apr 2025 | 250 | 0 | - | - | Stock Option (right to buy) | |
| Builders FirstSource | William Bradley Hayes | Director | Grant, award, or other acquisition of securities at price $ 138.99 per share. | 01 Mar 2025 | 269 | 13,511 (0%) | 0% | 139.0 | 37,388 | Common Stock, par value $0.01 per share |
| Builders FirstSource | William Bradley Hayes | Director | Grant, award, or other acquisition of securities at price $ 138.99 per share. | 01 Mar 2025 | 269 | 13,511 (0%) | 0% | 139.0 | 37,388 | Common Stock, par value $0.01 per share |
| Builders FirstSource | William Bradley Hayes | Director | Grant, award, or other acquisition of securities at price $ 186.47 per share. | 01 Dec 2024 | 201 | 13,242 (0%) | 0% | 186.5 | 37,480 | Common Stock, par value $0.01 per share |
| Builders FirstSource | William Bradley Hayes | Director | Grant, award, or other acquisition of securities at price $ 174.00 per share. | 01 Sep 2024 | 215 | 13,041 (0%) | 0% | 174 | 37,410 | Common Stock, par value $0.01 per share |
| Indaptus Therapeutics Inc | William Bradley Hayes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Builders FirstSource | William Bradley Hayes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 1,194 | 12,826 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Builders FirstSource | William Bradley Hayes | Director | Grant, award, or other acquisition of securities at price $ 160.79 per share. | 01 Jun 2024 | 233 | 11,632 (0%) | 0% | 160.8 | 37,464 | Common Stock, par value $0.01 per share |